Andrew Erickson
Papers
2
Total Citations
22
H-Index
2
About
Andrew Erickson is a leading researcher in the urological oncology, with a focused expertise in improving the clinical management of prostate cancer through advanced imaging and patient-centered outcomes. His key research areas include the integration of multiparametric MRI (mpMRI) into predictive nomograms and the long-term quality-of-life assessment of men on active surveillance. Dr. Erickson’s major contribution is demonstrating that adding prostate MRI to established clinical tools like the CAPRA, MSKCC, and Partin nomograms significantly enhances the prediction of adverse pathology and biochemical recurrence after radical prostatectomy. This work, cited 17 times, provides a practical pathway for more personalized surgical planning. Furthermore, his prospective analysis of the Finnish PRIAS active surveillance cohort, with over 11 years of follow-up, offers critical insights into the long-term health-related quality of life for men living with untreated low-risk prostate cancer. By quantifying the physical and mental health trajectories of these patients, Dr. Erickson’s research directly supports shared decision-making and helps validate active surveillance as a safe, sustainable option. His work bridges the gap between advanced imaging technology and real-world patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2